Investigation of Newly Developed Ostomy Products in Subjects With Ileostomy

December 8, 2015 updated by: Coloplast A/S

Investigation of Newly Developed 1-and 2-piece Convex Ostomy Products in Subjects With Ileostomy.

The aim of the investigation was to investigate the performance and safety of a new ostomy product.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

129

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Søborg, Denmark
        • TFS
      • Dijon cedex, France, 21079
        • Hôpital du Bocage
      • Libourne cedex, France, 33505
        • Hôpital Robert Boulin
      • Lille cedex, France, 59037
        • Hopital Claude Huriez
      • Marseille, France, 13015
        • Hopital Nord
      • Paris, France, 75020
        • Hôpital Tenon
      • Paris, France, 75014
        • Hopital Cochin
      • Pessac cedex, France, 33604
        • Hopital De Haut Leveque
      • Poitiers Cedex, France, 86021
        • CHRU La Milétrie
      • Aachen, Germany
        • BB medica medizinisches
      • Augsburg, Germany
        • Sanitätshause reinhold hilscher e.K.
      • Bad Staffelstein, Germany
        • Patientenberatung Strack e.K.
      • Berlin, Germany
        • Pro-samed Santitätshaus
      • Burgdorf, Germany
        • SIEWA Coloplast Homecare
      • Freising, Germany
        • SIEWA Coloplast Homecare
      • Leinfelden-echterdingen, Germany
        • SIEWA Coloplast Homecare
      • Leipzig, Germany
        • Schürmaier GmbH &Co
      • Passau, Germany
        • Sanitätshaus Fürst GmbH
      • Saulgrub, Germany
        • SIEWA Coloplast Homecare
      • Töppeln, Germany
        • Sanitäts- und gesundheitshaus Carqueville GmbH
      • Zwickau, Germany
        • Alippi GmbH
      • Larvik, Norway
        • Sykpleierklinikken
      • Boston, United Kingdom
        • Pilgrim Hospital
      • Cambridge, United Kingdom, CB20QQ
        • Addenbrookes
      • Gloucestershire, United Kingdom, GL53/AI
        • Cheltenham General Hospital
      • Lincoln, United Kingdom, LN25QY
        • Lincon Country hospital
      • London, United Kingdom, W68RF
        • Charing Cross Hospital
      • Northamptonshire, United Kingdom, NN168UZ
        • Kettering General Hospital
      • Suffolk, United Kingdom, IP332QZ
        • West Suffolk Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Are at least 18 years of age and have full legal capacity.
  2. Has had an ileostomy for at least 3 months.
  3. Has used a convex ostomy product for the last month.
  4. Has given signed informed consent.
  5. Has experienced seeping under the baseplate at least three times during the last two weeks.
  6. Currently using a SenSura Convex product with midi, maxi or magnum bags.
  7. Currently using a 1-piece product or a 2-piece product with a mechanical coupling ("click coupling").
  8. Has an ileostomy with a diameter of max 33 mm (1-piece product) or less. Or Has an ileostomy with a diameter of 30 mm (2-piece product) or less.

Exclusion Criteria:

  1. Has a loop-ostomy (double-barrel ostomy or ostomy with two outlets).
  2. Are pregnant or breastfeeding.
  3. Currently receiving, or has within the past 2 months received radio- and/or chemotherapy.
  4. Currently receiving, or has within the past month received steroid treatment (adrenocortical hormone) systemically or locally in the peristomal area.
  5. Currently suffering from peristomal skin problems i.e. bleeding or broken (weeping) skin.
  6. Are currently participating in another clinical intervention study or have previously participated in this one.
  7. Has a fistula in the peristomal area or less than 2 cm from the edge of the baseplate.
  8. Has known hypersensitivity toward the test product.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: First Coloplast test product

The subjects test:

test period 1: Coloplast test product test period 2: SenSura Convex Light

The Coloplast test product is a newly developed ostomy appliance
The comparator product is SenSura Convex Light, which is CE-marked and commercially available.
Other Names:
  • SenSura
Experimental: First SenSura Convex Light

The subjects test:

test period 1: SenSura Convex Light test period 2: Coloplast test product

The Coloplast test product is a newly developed ostomy appliance
The comparator product is SenSura Convex Light, which is CE-marked and commercially available.
Other Names:
  • SenSura

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Degree of Leakage
Time Frame: 28 +/- 3 days
The degree of leakage is measured using a 33-point scale measuring leakage under the baseplate, where 0 points represents the best possible outcome (no leakage) and 33 points the worst possible outcome (leakage on the whole baseplate).
28 +/- 3 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Daniel Carter, Coloplast A/S

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2013

Primary Completion (Actual)

June 1, 2014

Study Completion (Actual)

June 1, 2014

Study Registration Dates

First Submitted

October 18, 2013

First Submitted That Met QC Criteria

November 21, 2013

First Posted (Estimate)

November 26, 2013

Study Record Updates

Last Update Posted (Estimate)

January 12, 2016

Last Update Submitted That Met QC Criteria

December 8, 2015

Last Verified

December 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • CP232

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stoma Ileostomy

Clinical Trials on Coloplast test product

Subscribe